These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 9115851)

  • 41. [Evidence-based practice guideline for unresectable advanced lung cancer in 2003].
    Fukuoka M; Kurata T; Yamamoto N
    Nihon Geka Gakkai Zasshi; 2004 Jul; 105(7):412-6. PubMed ID: 15303441
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sequential chemoradiation therapy with vinorelbine, ifosfamide, and cisplatin in stage IIIB non-small cell lung cancer: a phase II study.
    Baldini E; Silvano G; Tibaldi C; Campoccia S; Cionini L; Conte P
    Semin Oncol; 2000 Feb; 27(1 Suppl 1):28-32. PubMed ID: 10697041
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A phase II trial of preoperative concurrent radiation therapy and weekly paclitaxel/carboplatin for patients with locally advanced non-small-cell lung cancer.
    Hainsworth JD; Gray JR; Litchy S; Bearden JD; Shaffer DW; Houston GA; Greco FA
    Clin Lung Cancer; 2004 Jul; 6(1):33-42. PubMed ID: 15310415
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Concurrent chemotherapy and thoracic irradiation in non-small cell lung cancer.
    Bonomi P; Reddy S; Faber LP
    Hematol Oncol Clin North Am; 1990 Dec; 4(6):1143-58. PubMed ID: 1962781
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Patterns of care survey (PCS) in lung cancer: how well does current U.S. practice with chemotherapy in the non-metastatic setting follow the literature?
    Langer CJ; Moughan J; Movsas B; Komaki R; Ettinger D; Owen J; Wilson JF
    Lung Cancer; 2005 Apr; 48(1):93-102. PubMed ID: 15777975
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Management of unresectable stage III non-small cell lung cancer: the role of combined chemoradiation.
    Penland SK; Socinski MA
    Semin Radiat Oncol; 2004 Oct; 14(4):326-34. PubMed ID: 15558508
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Management of resectable non-small cell lung cancer. Guidelines of clinical practice made by the European Lung Cancer Working Party].
    Sculier JP;
    Rev Med Brux; 2014; 35(3):134-9. PubMed ID: 25102579
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evolution of combined modality therapy for stage III non-small-cell lung cancer.
    Gandara DR; Edelman M; Lara P; Roberts P; Leigh B
    Oncology (Williston Park); 2000 Jul; 14(7 Suppl 5):35-41. PubMed ID: 10981289
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Trimodality therapy for non-small-cell lung cancer.
    Roberts JR
    Oncology (Williston Park); 1999 Oct; 13(10 Suppl 5):101-6. PubMed ID: 10550833
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multidisciplinary management of lung cancer.
    Debevec L; Debeljak A
    J Thorac Oncol; 2007 Jun; 2(6):577. PubMed ID: 17545858
    [No Abstract]   [Full Text] [Related]  

  • 51. Treatment of advanced (stages III and IV) non-small-cell lung cancer.
    Sweeney CJ; Sandler AB
    Curr Probl Cancer; 1998; 22(2):85-132. PubMed ID: 9580849
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rational integration of radiation and chemotherapy in patients with unresectable stage IIIA or IIIB NSCLC. Results from the Lung Cancer Study Group, Eastern Cooperative Oncology Group, and Radiation Therapy Oncology Group.
    Wagner H
    Chest; 1993 Jan; 103(1 Suppl):35S-42S. PubMed ID: 8380132
    [TBL] [Abstract][Full Text] [Related]  

  • 53. From radiotherapy to Targeted therapy: 20 years in the management of non-small-cell lung cancer.
    Weiss GJ; Bunn PA; Camidge DR
    Oncology (Williston Park); 2006 Nov; 20(12):1515-24; discussion 1524-5, 1530, 1535. PubMed ID: 17153906
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Combined-modality therapy of locally advanced non-small-cell lung cancer.
    Wagner H
    Oncology (Williston Park); 1997 Sep; 11(9 Suppl 9):43-50. PubMed ID: 9330408
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Adjuvant and neoadjuvant chemotherapy for non-small cell lung cancer: a time for reassessment?
    Bunn PA; Mault J; Kelly K
    Chest; 2000 Apr; 117(4 Suppl 1):119S-122S. PubMed ID: 10777465
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lung cancer highlights.
    Lynch TJ
    Oncologist; 1999; 4(4):279-86. PubMed ID: 10476538
    [No Abstract]   [Full Text] [Related]  

  • 57. Neoadjuvant Therapy in Non-Small Cell Lung Cancer.
    Zheng Y; Jaklitsch MT; Bueno R
    Surg Oncol Clin N Am; 2016 Jul; 25(3):567-84. PubMed ID: 27261916
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Consensus development conference on the medical treatment of non-small cell lung cancer: treatment of the early stages.
    Scagliotti G
    Lung Cancer; 2002 Dec; 38 Suppl 3():S23-9. PubMed ID: 12468140
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Combined modality therapy for early stage operable and locally advanced potentially resectable non-small cell lung carcinoma.
    Clark JI; Albain KS
    Cancer Treat Res; 2001; 105():149-70. PubMed ID: 11224986
    [No Abstract]   [Full Text] [Related]  

  • 60. Chemotherapy for advanced lung cancer. When to expect a response.
    Midthun DE; Jett JR
    Postgrad Med; 1997 Mar; 101(3):187-8, 191-2, 194 passim. PubMed ID: 9074558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.